Medication management error types: Associations with mild cognitive impairment subtype

被引:3
作者
De Vito, Alyssa N. [1 ,2 ]
Emrani, Sheina [3 ]
Hallowell, Emily [1 ,4 ]
Goldstein, Allyson [5 ]
Davis, Jennifer D. [1 ,5 ]
Margolis, Seth A. [1 ,5 ,6 ]
机构
[1] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Butler Hosp, Memory & Aging Program, Providence, RI USA
[3] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA
[4] Providence Vet Affairs Med Ctr, Dept Mental Hlth & Behav Sci & Serv, Providence, RI USA
[5] Rhode Isl Hosp, Dept Psychiat, Providence, RI USA
[6] Rhode Isl Hosp, Dept Psychiat, 110 Lockwood St,Suite 430, Providence, RI 02903 USA
关键词
Mild cognitive impairment; ecological validity; medication management; everyday functioning; medication management ability assessment; ABILITY ASSESSMENT; UNITED-STATES; DISEASE; PERSEVERATION; PERFORMANCE; MEMORY; ADULTS;
D O I
10.1080/13854046.2024.2339560
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Medication management errors are suspected to be prevalent among older adults with mild cognitive impairment (MCI). This study examined types of simulated medication-taking errors in cognitively normal older adults (CN; n = 131), single domain amnestic MCI (sdMCI, n = 91), and multi-domain MCI (mdMCI, n = 44). Errors were measured using the medication management ability assessment (MMAA). Methods: 266 participants seen for neuropsychological evaluation (94.4% White, 57.9% female, average age = 72, average education = 14 years) completed the MMAA (version 4.1), a performance-based task of medication management. Group differences in MMAA total scores, accuracy, and error types were evaluated using Kruskall-Wallis H tests. This study was the first to explore a newly operationalized error, perseverations, caused by taking a specific dose >= 2 times during the simulation. Results: CN and sdMCI groups had higher MMAA total scores than individuals with mdMCI, indicating better overall performance. The mdMCI group made a higher number of omission errors (missed pills) than other groups, but no differences were found for commission errors (extra pills). The sdMCI group made more perseverative errors compared to the CN group. Conclusions: Individuals with mdMCI made more simulated medication management errors than CN and sdMCI groups, indicating that they may be most vulnerable to difficulties in medication management. In contrast, sdMCI individuals were more likely to make perseverative errors, which may reflect a tendency towards overcompensation of memory loss. Future studies should assess whether MMAA performance is associated with patterns of real-world medication-taking in more diverse samples of older adults.
引用
收藏
页码:1931 / 1946
页数:16
相关论文
共 47 条
[1]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]  
[Anonymous], 2001, Boston naming test
[3]  
[Anonymous], 2004, Revised comprehensive norms for an expanded Halstead Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults
[4]  
[Anonymous], 2002, WPPSI-III Administration and Scoring Manual
[5]  
Beck A. T., 1996, Manual for Beck Depression Inventory-II
[6]   Revision of the brief visuospatial memory test: Studies of normal performance, reliability, and validity [J].
Benedict, RHB ;
Schretlen, D ;
Groninger, L ;
Dobraski, M ;
Shpritz, B .
PSYCHOLOGICAL ASSESSMENT, 1996, 8 (02) :145-153
[7]   VISUOSPATIAL JUDGMENT - CLINICAL TEST [J].
BENTON, AL ;
VARNEY, NR ;
HAMSHER, KD .
ARCHIVES OF NEUROLOGY, 1978, 35 (06) :364-367
[8]  
Brandt J., 1991, Clin Neuropsychol, V5, P125, DOI [DOI 10.1080/13854049108403297, 10.1080/13854049108403297]
[9]   Modifiable Risk Factors for Alzheimer's Disease [J].
Edwards, George A., III ;
Gamez, Nazaret ;
Escobedo, Gabriel, Jr. ;
Calderon, Olivia ;
Moreno-Gonzalez, Ines .
FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
[10]   Standardised assessment of patients' capacity to manage medications: A systematic review of published instruments [J].
Elliott R.A. ;
Marriott J.L. .
BMC Geriatrics, 9 (1)